drugset / Trial / NCT00409097
Effect of Rosiglitazone on ADMA in Critical Illness
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether Rosiglitazone,decreases the ADMA concentration and thereby increases the arginine/ADMA ratio of critically ill patients.
Timeline
- Start
- 2006-04
- Primary completion
- —
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosiglitazone | Small molecule | — | — |